Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection

被引:17
|
作者
Adebamowo, Sally N. [1 ,2 ]
Adeyemo, Adebowale A. [3 ]
Rotimi, Charles N. [3 ]
Olaniyan, Olayinka [4 ]
Offiong, Richard [5 ]
Adebamowo, Clement A. [1 ,2 ,6 ,7 ]
机构
[1] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 660 West Redwood St,Howard Hall,Room 119, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[3] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA
[4] Natl Hosp Abuja, Dept Obstet & Gynecol, Abuja, Nigeria
[5] Univ Abuja, Dept Obstet & Gynecol, Teaching Hosp, Abuja, Nigeria
[6] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA
[7] Inst Human Virol Nigeria, Abuja, Nigeria
关键词
LINE PROBE ASSAY; CANCER-CELLS; SUSCEPTIBILITY LOCI; CLINICAL-EVALUATION; GENE-TRANSCRIPTION; COLON-CANCER; LRH-1; MIR-365; EXPRESSION; APOPTOSIS;
D O I
10.1186/s12881-020-01156-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundGenetic factors may influence the susceptibility to high-risk (hr) human papillomavirus (HPV) infection and persistence. We conducted the first genome-wide association study (GWAS) to identify variants associated with cervical hrHPV infection and persistence.MethodsParticipants were 517 Nigerian women evaluated at baseline and 6months follow-up visits for HPV. HPV was characterized using SPF10/LiPA(25). hrHPV infection was positive if at least one carcinogenic HPV genotype was detected in a sample provided at the baseline visit and persistent if at least one carcinogenic HPV genotype was detected in each of the samples provided at the baseline and follow-up visits. Genotyping was done using the Illumina Multi-Ethnic Genotyping Array (MEGA) and imputation was done using the African Genome Resources Haplotype Reference Panel. Association analysis was done for hrHPV infection (125 cases/392 controls) and for persistent hrHPV infection (51 cases/355 controls) under additive genetic models adjusted for age, HIV status and the first principal component (PC) of the genotypes.ResultsThe mean (SD) age of the study participants was 38 (+/- 8) years, 48% were HIV negative, 24% were hrHPV positive and 10% had persistent hrHPV infections. No single variant reached genome-wide significance (p<5 X 10(-8)). The top three variants associated with hrHPV infections were intronic variants clustered in KLF12 (all OR: 7.06, p=1.43x10(-6)). The top variants associated with cervical hrHPV persistence were in DAP (OR: 6.86, p=7.15x10(-8)), NR5A2 (OR: 3.65, p=2.03x10(-7)) and MIR365-2 (OR: 7.71, p=2.63x10(-7)) gene regions.Conclusions This exploratory GWAS yielded suggestive candidate risk loci for cervical hrHPV infection and persistence. The identified loci have biological annotation and functional data supporting their role in hrHPV infection and persistence. Given our limited sample size, larger discovery and replication studies are warranted to further characterize the reported associations.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections
    Adebamowo, Sally N.
    Adeyemo, Adebowale
    Adebayo, Amos
    Achara, Peter
    Alabi, Bunmi
    Bakare, Rasheed A.
    Famooto, Ayotunde O.
    Obende, Kayode
    Offiong, Richard
    Olaniyan, Olayinka
    Ologun, Sanni
    Rotimi, Charles
    Adebamowo, Clement A.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 (06) : 708 - 716
  • [2] Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women
    Adebamowo, Sally N.
    Adeyemo, Adebowale A.
    [J]. HUMAN IMMUNOLOGY, 2019, 80 (09) : 723 - 730
  • [3] Classical HLA Alleles are Associated with Prevalent and Persistent Cervical High-Risk HPV Infection in African Women
    Adebamowo, Sally
    Adeyemo, Adebowale
    Adebamowo, Clement
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 : 62 - 62
  • [4] CERVICAL CYTOLOGY AND HIGH-RISK HUMAN PAPILLOMAVIRUS (HPV) INFECTION IN THE WOMEN WITH GENITAL CONDYLOMA
    Koo, Y.
    Kim, Y.
    Min, K.
    Hong, J.
    Lee, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 787 - 787
  • [5] Association between serum folate and vitamin B12 and cervical high-risk human papillomavirus (HPV) infection
    Peitz, Josephine
    Adebamowo, Clement Adebayo
    Adebamowo, Sally Nneoma
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Infection with high-risk Human Papillomavirus (HPV) and the risk of female infertility
    Nohr, B.
    Kjaer, S. Kruger
    Soylu, L.
    Jensen, A.
    [J]. HUMAN REPRODUCTION, 2017, 32 : 137 - 138
  • [7] Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection
    Takeuchi, Fumihiko
    Kukimoto, Iwao
    Li, Zhiqiang
    Li, Shuang
    Li, Ni
    Hu, Zhibin
    Takahashi, Atsushi
    Inoue, Shusaku
    Yokoi, Sana
    Chen, Jianhua
    Hang, Dong
    Kuroda, Makoto
    Matsuda, Fumihiko
    Mizuno, Mika
    Mori, Seiichiro
    Wu, Peng
    Tanaka, Naotake
    Matsuo, Keitaro
    Kamatani, Yoichiro
    Kubo, Michiaki
    Ma, Ding
    Shi, Yongyong
    [J]. HUMAN MOLECULAR GENETICS, 2019, 28 (02) : 341 - 348
  • [8] Cervical infection with human papillomavirus (HPV) 6 or 11 in high-risk women in Burkina Faso
    Low, Andrea
    Didelot-Rousseau, Marie-Noelle
    Nagot, Nicolas
    Ouedraougo, Abdoulaye
    Clayton, Tim
    Konate, Issouf
    Van de Perre, Philippe
    Segondy, Michel
    Mayaud, Philippe
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2010, 86 (05) : 342 - 344
  • [9] Alcohol consumption and persistent infection of high-risk human papillomavirus
    Oh, H. Y.
    Kim, M. K.
    Seo, S.
    Lee, D. O.
    Chung, Y. K.
    Lim, M. C.
    Kim, J.
    Lee, C. W.
    Park, S.
    [J]. EPIDEMIOLOGY AND INFECTION, 2015, 143 (07): : 1442 - 1450
  • [10] Treatment with paiteling for cervical high-risk human papillomavirus infection
    Tao, Pingping
    Meng, Xiaohua
    Chen, Junxia
    Sun, Aijing
    Shou, Qinghe
    Yang, Binlie
    Zheng, Weiping
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (05): : 4912 - 4918